Pharmaceutical News

RSS

Potential treatment for rare polio-like illness shows no signal of efficacy

Researchers have been searching for possible treatments for the polio-like illness causing paralysis in children, called acute flaccid myelitis.

9 Nov 2018

New oral drug reduces menstrual bleeding for women with common uterine tumors

A new oral drug significantly reduced menstrual bleeding for women with the most common gynecologic tumors in the United States - benign tumors that disproportionately affect African-Americans, an international clinical trial found.

9 Nov 2018

All infectious diseases likely to be seasonal

A new study has suggested that all infectious diseases are driven by seasonal elements, based on an analysis of 69 infectious diseases.

9 Nov 2018

Hypertonic saline shown to aid breathing in cystic fibrosis babies

The first-ever randomized controlled trial on babies with CF has found that treatment with inhaled hypertonic saline can improve breathing and lung health.

9 Nov 2018

Cholesterol-lowering drug reduces chance of having second heart problems or stroke

In a clinical trial involving 18,924 patients from 57 countries who had suffered a recent heart attack or threatened heart attack, researchers at the University of Colorado Anschutz Medical Campus and fellow scientists around the world have found that the cholesterol-lowering drug alirocumab reduced the chance of having additional heart problems or stroke.

8 Nov 2018

CDK2 protein plays key role in heart damage caused by doxorubicin, finds study

A new study by Washington State University researchers suggests that a protein called CDK2 plays a critical role in heart damage caused by doxorubicin, a commonly used chemotherapy drug.

8 Nov 2018

New study shows promise of innovative strategy against HER2-driven lung cancers

The HER2 gene is a well-known driver of breast cancer, where changes in this gene are found in about 1-in-5 cases of the disease. HER2 also contributes to about 3 percent of lung cancers, representing about 6,500 patients per year.

8 Nov 2018

Cannabinoids hold promise in treating children with epilepsy

In recent years, cannabinoids--the active chemicals in medical marijuana-- have been increasingly touted as a potential treatment for a range of neurological and psychiatric disorders. In a Developmental Medicine & Child Neurology review, investigators compare their efficacy with antiepileptic drugs for children with epilepsy.

7 Nov 2018

Study highlights need for interventions to improve statin use among older adults

In a British Journal of Clinical Pharmacology study of older adults prescribed statins, first-year nonadherence and discontinuation rates were high.

7 Nov 2018

New AI technology can potentially reduce bottlenecks in drug research

Researchers at the University of Waterloo have developed a new system that could significantly speed up the discovery of new drugs and reduce the need for costly and time-consuming laboratory tests.

7 Nov 2018

Study finds rapid increase in overdose deaths involving amphetamines and methamphetamines

The number of overdose deaths involving methamphetamines and amphetamines in the state of Ohio increased more than 5,000 percent over the course of eight years, according to data collected by the Ohio Alliance for Innovation in Population Health.

7 Nov 2018

New study supports use of antibiotic prophylaxis in patients undergoing invasive dental treatment

New research has revealed the impact a change in US guidelines had on the prescribing of antibiotic prophylaxis to prevent a life-threatening heart condition infective endocarditis in patients before undergoing invasive dental treatment.

5 Nov 2018

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved LORBRENA, a third-generation anaplastic lymphoma kinase tyrosine kinase inhibitor for patients with ALK-positive metastatic non-small cell lung cancer whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease; or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

5 Nov 2018

Experts identify barriers to using stroke-preventing anticoagulants in Canada

International guidelines recommend direct oral anticoagulants over warfarin to prevent stroke for most patients with atrial fibrillation.

5 Nov 2018

Genetics can be used to predict schizophrenic patient's response to antipsychotic drugs

Genetics can be used to predict a patient's response to antipsychotic drug treatment for schizophrenia, according to a recent study by investigators at The Feinstein Institute for Medical Research. The findings were published online today in the American Journal of Psychiatry.

5 Nov 2018

Researchers observe cognitive changes in offspring of rats exposed to high cannabis doses

Washington State University researchers have seen cognitive changes in the offspring of rats exposed to heavy amounts of cannabis. Their work is one of the rare studies to look at the effects of cannabis during pregnancy.

5 Nov 2018

New heart drug spotlights troubling trends in drug marketing

At the end of September, Amarin Corp. teased some early findings for Vascepa, its preventive medicine for people at risk of heart disease.

2 Nov 2018

New way of identifying potential cancer drugs could streamline development of therapies

A new way of identifying potential cancer drugs could streamline the development of therapies, following a discovery by scientists.

2 Nov 2018

Wellspring celebrates grand opening of its compounding pharmacy division

Wellspring celebrated its compounding pharmacy division's grand opening with a ribbon cutting attended by over 60 guests, including Berkeley Mayor Jesse Arreguín, on Tuesday, October 30th at its new location.

2 Nov 2018

Certain test strips used with home-use devices may provide inaccurate results, warns FDA

The U.S. Food and Drug Administration today is warning patients and doctors, who use at-home or in-the-office medical devices to monitor levels of the blood thinner, warfarin, that certain test strips used with the devices may provide inaccurate results and should not be relied upon to adjust the drug dosage.

2 Nov 2018

Pharmaceutical News

Potential treatment for rare polio-like illness shows no signal of efficacy

New oral drug reduces menstrual bleeding for women with common uterine tumors

All infectious diseases likely to be seasonal

Hypertonic saline shown to aid breathing in cystic fibrosis babies

Cholesterol-lowering drug reduces chance of having second heart problems or stroke

CDK2 protein plays key role in heart damage caused by doxorubicin, finds study

New study shows promise of innovative strategy against HER2-driven lung cancers

Cannabinoids hold promise in treating children with epilepsy

Study highlights need for interventions to improve statin use among older adults

New AI technology can potentially reduce bottlenecks in drug research

Study finds rapid increase in overdose deaths involving amphetamines and methamphetamines

New study supports use of antibiotic prophylaxis in patients undergoing invasive dental treatment

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Experts identify barriers to using stroke-preventing anticoagulants in Canada

Genetics can be used to predict schizophrenic patient's response to antipsychotic drugs

Researchers observe cognitive changes in offspring of rats exposed to high cannabis doses

New heart drug spotlights troubling trends in drug marketing

New way of identifying potential cancer drugs could streamline development of therapies

Wellspring celebrates grand opening of its compounding pharmacy division

Certain test strips used with home-use devices may provide inaccurate results, warns FDA

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News